US to pay Pfizer nearly $2 billion for more Paxlovid courses in 2023
The new purchase supplements the 20 million courses previously bought by the US, and are planned for delivery by early 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US Federal Court dismisses cancer linkage associated with Zantac
The current ruling will assure the safety of the use of ranitidine for Indian patients
Takeda launches Cinryze in India for prophylaxis in hereditary angioedema patients
Cinryze is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure…
Haiti receives first shipments of cholera vaccines: WHO
The WHO said the vaccination campaign was set to start in the next few days and would initially target children from one-year old…
Indonesia to produce Merck’s HPV vaccines to combat cervical cancer
Honesti Basyir, Chief, Bio Farma, said in a statement that the company has signed a technology transfer deal with Merck to help…
Ministry of AYUSH takes steps to assure quality of AYUSH drugs
The information was given by Sarbananda Sonowal, Minister of AYUSH, in Rajya Sabha, yesterday
Roche appoints Thomas Schinecker as new Group CEO
The company will propose Severin Schwan as the new Chairman at the Annual General Meeting in 2023
Smaller batches and 50 per cent higher OEE
B&R recently announced plans to strengthen its presence in the medical device assembly market. Fredrik Holmberg, Head, Global…
Pfizer sees $10-$15 billion in annual mRNA vaccine revenue by 2030
The company provided potential revenue details from vaccines across its portfolio, including its already-approved COVID-19 vaccine…
Australia’s CSL names insider Paul McKenzie as CEO
CSL makes most of its money paying people in the United States (US) for blood plasma, which it uses for treatments of rare…